BMS-212122 ( —— )

产品货号. M34524 CAS No. 194213-64-4

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

BMS-212122
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

BMS-212122 (UNII-0Z473OO6GB) is a potent inhibitor of microsomal triglyceride transfer protein (MTP) and has shown hypolipidemic effects in animal studies.BMS-212122 significantly reduced lipid content and monocyte-derived (CD68+) cells in atherosclerotic plaques.
产品描述

BMS-212122 (UNII-0Z473OO6GB) is a potent inhibitor of microsomal triglyceride transfer protein (MTP) and has shown hypolipidemic effects in animal studies.BMS-212122 significantly reduced lipid content and monocyte-derived (CD68+) cells in atherosclerotic plaques.
体外实验

——
体内实验

——
同义词

——
通路

Metabolic Enzyme/Protease
靶点

CETP
受体

CETP
研究领域

——
适应症

——

CAS Number

194213-64-4
分子量

754.76
分子式

C43H36F6N4O2
纯度

>98% (HPLC)
溶解度

——
SMILES

C(NCC(F)(F)F)(=O)C1(CCCCN2C=3C(N=C2C)=C(NC(=O)C4=C(C=CC=C4)C5=CC=C(C(F)(F)F)C=C5)C(C)=CC3)C=6C(C=7C1=CC=CC7)=CC=CC6
化学全称

——

计算器

产品手册

关联产品

BMS-212122

BMS-212122 (UNII-0Z473OO6GB) is a potent inhibitor of microsomal triglyceride transfer protein (MTP) and has shown hypolipidemic effects in animal studies.BMS-212122 significantly reduced lipid content and monocyte-derived (CD68+) cells in atherosclerotic plaques.
Lomitapide Mesylate

Lomitapide Mesylate 是一种有效的微粒体甘油三酯转移蛋白 (MTP) 抑制剂，用于治疗家族性高胆固醇血症。
SR17018

SR17018 是一种 mu-阿片受体 (MOR) 激动剂，与 GTPγS 结合，EC50 为 97 nM。